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Background: Corneal intrastromal injection is an important mode of gene-vector application to subepithelial layers.
In a mouse model, this procedure is substantially complicated by the reduced corneal dimensions. Furthermore,
it may be difficult to estimate the corneal area reached by the volume of a single injection. This study aimed to
investigate intrastromal injections into the mouse cornea using different microneedles and to quantify the effect of
injecting varying volumes. A reproducible injection technique is described.
Methods: Forty eyes of 20 129 Sv/J mice were tested. India ink was intrastromally injected using 30° beveled 33 G
needles, tri-surface 25° beveled 35 G needles, or hand-pulled and 25° beveled glass needles. Each eye received a
single injection of a volume of 1 or 2 μL. Corneoscleral buttons were fixed and flat mounted for computer-assisted
quantification of the affected corneal area. Histological assessment was performed to investigate the intrastromal
location of the injected dye.
Results: A mean corneal area of 5.0 ±1.4 mm2 (mean ± SD) and 7.7 ±1.4 mm2 was covered by intrastromal
injections of 1 and 2 μL, respectively. The mean percentage of total corneal area reached ranged from 39% to 53%
for 1 μL injections, and from 65% to 81% for 2 μL injections. Injections using the 33 G needles tended to provide
the highest distribution area. Perforation rates were 8% for 30° beveled 33 G needles and 44% for tri-surface
beveled 35 G needles. No perforation was observed with glass needle; however, intrastromal breakage of needle
tips was noted in 25% of these cases.
Conclusions: Intracorneal injection using a 30° beveled 33 G needle was safe and effective. The use of tri-surface
beveled 35 G needles substantially increased the number of corneal perforations. Glass needles may break inside
the corneal stroma. Injections of 1 μL and 2 μL resulted in an overall mean of 49% and 73% respectively of total
corneal area involved.
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Effective corneal gene therapy will require safe and ef-
fective gene delivery. However, lacrimation, mucus,
blinking of the eyelid, and tight junctions of the corneal
epithelium are a significant obstacle to genetic vectors
[1,2]. Accordingly, intrastromal or intracameral injec-
tions are generally used for delivery of genetic therapeu-
tics to subepithelial corneal layers [1].
Corneal thickness substantially varies among different
animal species [3]. It is reported to be approximately* Correspondence: aljun@jhmi.edu
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reproduction in any medium, provided the or354 μm in rabbits and 170 μm in rats, while it is only
89.2 to 123.8 μm in mice [3,4]. Therefore, many studies
in animals using corneal injections have used species
other than mouse. However, the basic advantages of a
mouse model are well-known: genetic models are often
already available or easily practicable, experimental
methods are usually better established, and expenses are
comparably low. Thus, some studies describing the tech-
nique of intrastromal injections in mice have been con-
ducted [5-17]. According to the method first described
by Epstein and Stulting [9], most of these studies used a
33 gauge (G) needle with a bevel of 30° or 45° and the
injected volume generally varied up to 2 μL [5-7,9-13]. It
is important to consider that this variation may causeal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Needles used for intrastromal injections. (A) Hamilton
33 G 30° beveled, (B) WPI 35 G 25° tri-surface beveled, (C) WPI glass
needle hand-pulled from 1 mm diameter glass capillary to an inner
diameter of approximately 50 μm and 25° beveled.
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fluid or therapeutic agent.
The major difficulties of injecting a mouse cornea are
posed by its reduced thickness and the handling of a
comparably large needle. Improved injection systems,
like foot-pedal driven pumps and smaller gauged needles
made of glass, are supposed to simplify the procedure
but may cause problems like plugging or breakage of the
needle tip, and they are more expensive than standard
hand-held syringes [8,15].
The present article describes a modified and reprodu-
cible injection method using hand-held syringes. In a
systematic assessment, we compared injections into the
mouse cornea by different types of microneedles and
syringes and quantified the area reached by injections of
different volumes.
Methods
Animals
129 Sv/J mice were bought from the Jackson Laboratory
(The Jackson Laboratory, Bar Harbor, ME, USA). Ani-
mals ranged in age from 6 to 8 months. All procedures
occurred according to the Association for Research in
Vision and Ophthalmology statement for the Use of
Animals in Ophthalmic and Vision Research.
Needles and syringes
Needles and syringes were obtained as follows (see
Table 1 and Figure 1): 33 G needles (Hamilton, Reno,
NV, USA) were attached to a 2.5 μL syringe (Hamilton);
35 G needles (WPI, Sarasota, FL, USA) were attached to
a 10 μL syringe (WPI); glass needles were hand-pulled
from 1 mm diameter glass capillaries (WPI) and beveled
to 25° and an inner tip diameter of approximately
50 μm. Glass needles were attached to a 2.5 μL syringe
(Hamilton) by a dual ferrule adaptor (Hamilton).
Injected solution
Higgins Black India Ink (Chartpak, Leeds, MA. USA)
was centrifuged for 10 min at 10,000 rpm. The super-
natant was passed through a 0.2 μm sterile filter (Corn-
ing, Corning, NY, USA) prior to injection.Table 1 Specification of microneedles used for intrastromal in
Needle type Material Bevel
(degree)
Nomin
diamet
Hamilton, 33 G, point style 4 stainless
steel
30 0.210
WPI, 35 G, tri-surface bevel stainless
steel
25 0.135
WPI, hand-pulled and
beveled glass needle
glass 25 0.060a
aapproximate measurements.Intracorneal injection technique
For anesthesia, a weight-adjusted combination of keta-
mine (100 mg/kg, Sigma-Aldrich, St. Louis, MO, USA),
xylazine (20 mg/kg, Bioniche Pharma, Lake Forest, IL,
USA) and acepromazine (3 mg/kg, Sigma-Aldrich) was
administered by intraperitoneal injection. Both eyes
received an intracorneal injection of dye. All injections
were performed by the same investigator (MM) after a
period of 1 to 2 months of weekly training. Before each
injection, proparacaine hydrochloride 0.5% eye dropsjections
al outer
er (mm)
Nominal inner
diameter (mm)
Total length
(mm)
0.110 9.520
0.055 35.000
0.050a 10.000a
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floxacin eye drops (Vigamox; Alcon Laboratories, Fort
Worth, TX, USA) were applied. All procedures occurred
under a Nikon SMZ800 dissection microscope (Nikon,
Melville, NY, USA). The anesthetized mouse was placed
on a Styrofoam platform, and the head was stabilized
using a thin strip of non-latex material fashioned from a
disposable laboratory glove. The strip was thin enough
not to occlude the nostrils of the mouse. A small hole
was pre-cut into the strip to allow protrusion of the
globe. The eye was cautiously proptosed by forceps
retracting the upper and lower lid (Figure 2A). After fix-
ation under the strip, the proptosis was maintained by
tension along the margins of the pre-cut hole and the
forceps were withdrawn. Care was taken that the strip
did not strangle the central ocular blood vessels and
optic nerve.
In the corneal mid-periphery, a small nick was made
down to the anterior stroma with a 30 G beveled needle
(Becton Dickinson, Franklin Lakes, NJ, USA) (Figure 2B);
the needle was slightly moved tangentially and upwards
without withdrawal to confirm stromal placement. This
created a small intrastromal pocket by separating the
stromal lamellae, as could be observed by opacification
of the anterior stroma (Figure 2B). A second smaller
needle (see Table 1) was inserted into the pocket
(Figure 2C). It was slowly tangentially pushed forward
towards the corneal center until the tip of the needle had
reached a position where approximately 0.5 mm of the
needle shaft had entered the corneal stroma (Figure 2C).
At this point, the India ink was forcefully injected with-
out moving the needle tip (Figure 2D), and the needle
subsequently was retracted. A perforation of the corneaFigure 2 Intrastromal injection of a mouse cornea. (A) Proptosis
of the eye by careful retraction of upper and lower lid with a
forceps, (B) creation of a small intrastromal pocket in the
mid-peripheral cornea using a 30 G needle, (C) insertion of a smaller
needle and intrastromal advancement towards the corneal center,
(D) forceful injection of India ink.was indicated by a sudden flattening of the anterior
chamber, a temporary darkening of the aqueous humor
by the ink, or leakage of clear aqueous humor from the
injection site. All eyes with a corneal perforation were
excluded for subsequent investigations from the study.
Mice were euthanized 30 minutes after the injection, and
both eyes were enucleated for further assessment, as
described below.
Quantitative analysis
After enucleation, whole globes were fixed in 4% paraf-
ormaldehyde in phosphate-buffered saline for 1 h at
room temperature and the tissue was equilibrated in
20% sucrose solution at 4°C overnight. Subsequently,
corneal buttons, including a narrow scleral rim, were
excised. Four radial incisions were made and corneas
were flat mounted on a glass slide. Pictures were taken
at 5× magnification under the dissection microscope
using a Canon VIXIA HFS21 digital camera (Canon,
Lake Success, NY, USA). The injected corneal area could
clearly be identified by a black staining of the tissue. The
borders of the total corneal area were marked by
Schwalbe’s line. The injected area and total corneal area
were measured using the ImageJ 1.43 software (National
Institutes of Health, Bethesda, MD, USA).
Histological evaluation
Eight mouse eyes were processed for histological evalu-
ation after intracorneal injection to assess the intrastro-
mal location of the injected fluid. After enucleation, eyes
were fixed as described above. Excised corneoscleral but-
tons were embedded in Tissue Tek OCT compound
(Sakura Finetek, Torrance, CA, USA) at −80°C. Cryosec-
tions of 10 μm were examined by hematoxylin-eosin
staining.
Statistics
The stained areas of different groups were compared
using the one-tailed Mann–Whitney nonparametric test.
A P-value of <0.05 was regarded as statistically signifi-
cant. Statistical software used included Excel 2008 for
Mac (Microsoft, Redmond, WA, USA) and GraphPad
Prism 4 (GraphPad, La Jolla, CA, USA).
Results
The mean total corneal endothelial surface was 10.52
±0.74 mm2. Examples of flat mounted murine corneas
after 1 and 2 μL injection using different needles are
presented in Figure 3. Intracorneal injections of a vol-
ume of 1 μL India ink resulted in a significantly
(P<0.05) smaller mean affected area (5.0 ±1.4 mm2)
than injections of a volume of 2 μL (7.7 ±1.4 mm2). This
difference was also significant (P<0.05) for 1 and 2 μL
injections with each needle type.
Figure 3 Flat mounts of 4% paraformaldehyde-fixed mouse corneas after intrastromal India ink injections. (A,B,C) Mouse corneas after
injection of 1 μL and (D,E,F) 2 μL using a 33 G 30° beveled needle (A and D), a 35 G 25° tri-surface beveled needle (B and E) and a hand-pulled
and beveled glass needle (C and F).
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tendency to affect the largest absolute dyed areas (1 μL:
5.6 ±1.3 mm2, 2 μL: 8.6 ±1.6 mm2), while injections with
WPI 35 G needles (1 μL: 5.1 ±1.4 mm2, 2 μL: 7.3
±0.8 mm2) and glass needles (1 μL: 4.1 ±1.3 mm2, 2 μL:
6.8 ±1.2 mm2) tended to provide smaller absolute
affected areas (Figure 4). However, these differences be-
tween needles showed no statistical significance. The
percentages of total corneal areas that were involved
after a single injection of 1 or 2 μL ink are displayed for
each needle type in Table 2. The mean proportionally
affected corneal area was 49 ±14% for 1 μL volume of
injection and 73 ±15% for 2 μL volume of injection, as
displayed in Figure 5 (P<0.05).
A perforation of the cornea occurred in one case (8%)
using 33 G needles, in eight cases (44%) using 35 G
needles, and in no case using hand-pulled glass needles.Figure 4 Corneal area affected after intrastromal injection of
1 μL or 2 μL India ink using different needle types. * P<0.05
compared with 1 μL injection using same needle type.For the glass needles, a breakage of the tip occurred in
two cases (25%). A small amount of leakage was noted
in all cases.
Histological assessment of injected corneas revealed a
separation of the stromal lamellae and an interlamellar
dispersion of the India ink in all cases, as can be seen in
Figure 6.
Discussion
Due to its clarity, accessibility and clinical relevance, the
cornea provides an excellent tissue for studies of gene
transfer [18-20]. Gene delivery into subepithelial layers via
topically-administered drops is hampered by tear flow, pro-
tective mucus layers, blinking and epithelial tight junctions.
Intrastromal injection provides an important route to over-
come these barriers. Despite the advantage of mouse mod-
els for corneal gene therapy studies, intrastromal injections
in mice are difficult due to the small corneal thickness, and
studies using intrastromal injections in the mouse cornea
report corneal perforation rates up to 15% [9,15].Table 2 Percentage of total corneal area affected after
intrastromal injection of India ink
Needle type 1 μL injection 2 μL injection
Percentage of total
area affected
(mean± SD)
n Percentage of total
area affected
(mean± SD)
n
Hamilton, 33 G 53.28 ± 12.37 7 80.63 ± 14.28 6
WPI, 35 G 50.43 ± 16.14 5 65.29 ± 6.75 5
WPI, glass needle 38.67 ± 9.03 4 69.65 ± 19.09 4
Total 48.74 ± 13.59 16 72.59 ± 14.60 15
Figure 5 Percentage of corneal area affected after intrastromal
injection of 1 or 2 μL India ink. * P<0.05 compared with 1 μL
injection.
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increases towards the center [21]. This largely explains
the method commonly used for intrastromal injection
in mice, which involves a nick in the epithelium and an-
terior stroma made in the mid-periphery with a larger
(30 to 32 G) needle. Subsequently, a finer needle is
introduced and pushed forward, thereby separating the
stromal fibers towards the center where the injection
occurs. As described above in detail, we also applied this
method but modified the mode of globe fixation.
The aim of this study was a systematic comparison of
intrastromal injections using different microneedles in the
mouse eye. Furthermore, our goal was to assess the cornealFigure 6 Histology of a mouse cornea after intrastromal
injection of India ink. Separation of the stromal lamellae and
intrastromal dispersion of the India ink. Hematoxylin and eosin
staining.areas that may be affected by single injections of different
volumes. Overall, the ratio between injected volume and
the affected corneal area was reproducible. However, the
ratio of injected volume and affected corneal area did not
rise proportionally. This may have been caused by the leak-
age that was observed in all cases. The leakage is likely to
rise with increasing volume of the injection, perhaps due
to increased pressure inside the stroma. The volume of
leakage was difficult to quantify, but appeared noticeably
greater for the larger (2 μL) injection volumes. Regardless,
injected fluid was delivered to a large portion of the cor-
neal surface area with 2 μL injected volume.
There was a trend towards a reduced involved area
with a decrease of the inner diameter of the microneedle.
However, these results were not statistically significant.
The perforation rate of 8% that was achieved with the
33 G needle is acceptable for practical use in most ex-
perimental studies. Using the tri-surface beveled 35 G
needle, a perforation rate as high as 44% was observed.
This was most likely caused by the sharp tip of the tri-
surfaced bevel that did not give rise to a separation of
the stromal fibers, but rather caused an easier penetra-
tion of the anterior chamber. The best results with re-
gard to the rate of perforation were achieved using glass
needles. However, in 25% of all cases, a breakage of the
glass needle tip occurred inside the corneal stroma. This
may cause additional tissue trauma in the postoperative
course, which may be undesirable.
It was previously reported that a major drawback of
hand-held syringes for injection of mouse eyes may be the
difficulty of keeping the needle tip in the injection area
while depressing the plunger [15]. According to our ex-
perience, this problem is mainly caused by ineffective eye-
fixation using forceps that are held with the non-injecting
hand. The above-mentioned method of fixation with a
strip of elastic material allowed for safe proptosis and fix-
ation of the eye so that the injection could be administered
more reliably. One disadvantage of this technique is the
low risk of compression of the ophthalmic artery, vein or
optic nerve, and care must be taken to avoid this compli-
cation by proper placement of the strip.
The use of a gas-powered or foot-pedal driven micro-
injection system may lead to a smoother course of the in-
jection procedure and may, therefore, prevent the breakage
of glass needle tips within the cornea. In this case, the use
of hand-pulled glass needles could provide a safe and
atraumatic method for intrastromal injections. When using
hand-held syringes as in our study, however, the use of
33 G metal needles provided the most reliable and effective
outcomes.
Conclusions
Using the described technique intracorneal injection with
a 30° beveled 33 G needle was safe and effective. The
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cible guideline for intracorneal injections into the mouse
cornea, and should facilitate use of mouse models for cor-
neal gene therapy studies.
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